Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 4/20 | 0.44 |
| ▸ | PKM | P14618 | 2/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.44 |
| ▸ | ALPI | P09923 | 1/20 | 0.44 |
| ▸ | XIAP | P98170 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | RGS12 | O14924 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14441259 | 1.00 | SLC7A5 (0.44) | SLC7A5PKMPTGS1ALPIXIAP | |
| SCHEMBL5300667 | 1.00 | SLC7A5 (0.44) | SLC7A5PKMPTGS1ALPIXIAP | |
| SCHEMBL14023473 | 0.84 | SLC7A5 (0.41) | SLC7A5PKMPTGS1ALPIXIAP | |
| SCHEMBL1076502 | 0.74 | SLC7A5 (0.44) | SLC7A5PKMPTGS1ALPIXIAP | |
| SCHEMBL3278753 | 0.74 | SLC7A5 (0.41) | SLC7A5PKMPTGS1ALPIXIAP | |
| SCHEMBL6009735 | 0.71 | USP2 (0.42) | SLC7A5PKMPTGS1ALPIXIAP | |
| SCHEMBL23996206 | 0.71 | MAPT (0.39) | SLC7A5PKMPTGS1ALPIXIAP | |
| SCHEMBL29280376 | 0.70 | SLC7A5 (0.46) | SLC7A5PKMPTGS1ALPIXIAP | |
| SCHEMBL4994581 | 0.70 | SLC7A5 (0.46) | SLC7A5PKMPTGS1ALPIXIAP | |
| SCHEMBL25737316 | 0.69 | SLC7A5 (0.37) | SLC7A5PKMPTGS1ALPIXIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250276107-A1 | HYDROGEL SYSTEMS AND METHODS FOR TREATING FISTULA AND OTHER INDICATIONS | TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION (US) | 2025-09-04 | — | — | US | claimed |
| US-20250176872-A1 | SYSTEMS AND METHODS FOR SENSING LEVODOPA | DEXCOM, INC. (US) | 2025-06-05 | — | — | US | claimed |
| WO-2024258183-A1 | SKIN SOOTHING OR ANTI-INFLAMMATORY COMPOSITION COMPRISING METAL-PHENOLIC COMPLEX AND MELANIN OR PRECURSOR THEREOF | 코스맥스 주식회사 | 2024-12-19 | — | — | WO | claimed |
| WO-2024258187-A1 | COMPOSITION FOR STRENGTHENING HAIR ROOTS COMPRISING METAL-PHENOLIC COMPLEX AND MELANIN OR PRECURSOR THEREOF | 코스맥스 주식회사 | 2024-12-19 | — | — | WO | claimed |
| WO-2024258190-A1 | HAIR DYE COMPOSITION FOR PREMATURE GRAY HAIR AND METHOD FOR PREPARING SAME | 코스맥스 주식회사 | 2024-12-19 | — | — | WO | claimed |
| WO-2024258193-A1 | METAL-PHENOL COMPLEX AND DYEING COMPOSITION COMPRISING MELANIN OR PRECURSOR THEREOF | 코스맥스 주식회사 | 2024-12-19 | — | — | WO | claimed |
| EP-4436989-A1 | SKIN MIMICRY COMPOSITIONS AND IMPLANTS | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2024-10-02 | — | — | EP | claimed |
| WO-2023095134-A1 | SKIN MIMICRY COMPOSITIONS AND IMPLANTS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2023-06-01 | — | — | WO | claimed |
| US-12611369-B2 | Skin mimicry compositions and implants | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2026-04-28 | — | — | US | disclosed |
| US-20260108446-A1 | HYDROXYQUINOLINE COMPOUNDS AND METHODS OF USE AS PIGMENT MODIFYING AGENTS | GERMANAS JURIS (US) | 2026-04-23 | — | — | US | disclosed |
| EP-4729513-A1 | A-KETO ACID AMIDE OR SUBSTITUTED OXALIC ACID AMIDE ESTER COMPOUND AND COMPOSITION THEREOF | Nanjing Chempion Biotechnology Co., Ltd. (CN) | 2026-04-22 | — | — | EP | disclosed |
| EP-4727954-A1 | HEPARAN SULFATE GLYCOMIMETIC COMPOUNDS, THEIR USES AND INTERMEDIATES FOR THEIR PREPARATION | Victoria Link Limited (NZ) | 2026-04-22 | — | — | EP | disclosed |
| US-12605323-B2 | Composition for inhibiting hair graying, and use thereof | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2026-04-21 | — | — | US | disclosed |
| EP-4724565-A2 | METHODS FOR PRODUCING MODIFIED BETALAINS IN YEAST | Danmarks Tekniske Universitet (DK) | 2026-04-15 | — | — | EP | disclosed |
| US-20080287536-A1 | Skin and Hair Restoration by Natural Amino Acid and Peptide Crown Complexes | BIODERM RESEARCH (US) | 2008-11-20 | — | — | US | disclosed |
| US-20080286219-A1 | Hydroquinone derivative skin brightening compounds | EASTMAN CHEMICAL COMPANY | 2008-11-20 | — | — | US | disclosed |
| US-7427690-B2 | Multifunction “crown complexes” from amino acids and peptides for skin and hair restoration | BIODERM RESEARCH (US) | 2008-09-23 | — | — | US | disclosed |
| EP-1073418-B1 | AQUEOUS COMPOSITION COMPRISING ACTIVE INGREDIENTS FOR THE DE-PIGMENTATION OF THE SKIN | UNIVERA PHARM INC (US) | 2007-12-05 | — | — | EP | disclosed |
| US-20070099886-A1 | Multifunction \"Crown Complexes\" from Amino Acids and Peptides for Skin and Hair Restoration | BIODERM RESEARCH (US) | 2007-05-03 | — | — | US | disclosed |
| US-5859198-A | ADHESIVE PROTEINS ISOLATED FROM ALGAE WHICH DO NOT CONTAIN HYDROXYPROLINE OR 3,4-DIHYDROXYPHENYL-L-ALANINE | BIOTA LTD. (IL) | 1999-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080286219-A1 | Hydroquinone derivative skin brightening compounds | NQO1, CUTA, TYR | SLC7A5 2248/4885PKM 3475/4885PTGS1 421/4885 |
| US-20260108446-A1 | HYDROXYQUINOLINE COMPOUNDS AND METHODS OF USE AS PIGMENT MODIFYING AGENTS | TYR, TFEB, MC1R | SLC7A5 748/4885PKM 870/4885PTGS1 1556/4885 |
| US-20080287536-A1 | Skin and Hair Restoration by Natural Amino Acid and Peptide Crown Complexes | MMP17, MC1R, TYR | SLC7A5 150/4885PKM 2063/4885PTGS1 436/4885 |
| US-12605323-B2 | Composition for inhibiting hair graying, and use thereof | CTNND1, CTNNB1, GSK3B | SLC7A5 430/4885PKM 4046/4885PTGS1 2229/4885 |
| US-12611369-B2 | Skin mimicry compositions and implants | TYR, KRT18, MARK1 | SLC7A5 1683/4885PKM 54/4885PTGS1 3510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.